Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Washington University School of Medicine
Eastern Cooperative Oncology Group
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
The Lymphoma Academic Research Organisation
Fondazione Italiana Linfomi - ETS
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Ruijin Hospital
University of Miami
AIDS Malignancy Consortium
Memorial Sloan Kettering Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Academic and Community Cancer Research United
Roswell Park Cancer Institute
University of Nebraska
M.D. Anderson Cancer Center
Washington University School of Medicine
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska
Seoul National University Hospital
M.D. Anderson Cancer Center
Fondazione Italiana Linfomi - ETS
M.D. Anderson Cancer Center
The First Affiliated Hospital with Nanjing Medical University
SWOG Cancer Research Network
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Celgene
M.D. Anderson Cancer Center
City of Hope Medical Center
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
European Mantle Cell Lymphoma Network
Fujian Medical University
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Barbara Ann Karmanos Cancer Institute